This event aims to bring together experts to discuss the potential causes and challenges in the diagnosis and treatment of lung cancer in never smokers. Prior to the event, delegates will be asked to complete a survey identifying key unanswered questions in the field. These questions will then be brought forward to shape the discussion session at the event, and this work will help the NCRI Lung Group build their strategy which we hope will influence funders into giving more attention to this area of unmet need. You can view the full agenda by clicking here.


  • Professor Matthew Hatton, Sheffield Teaching Hospitals NHS Foundation Trust
  • Dr Frank McCaughan, The University of Cambridge
  • Dr Philip Crosbie, The University of Manchester


  • Mrs Janette Rawlinson, National Cancer Research Institute
  • Dr Amelia Randle, NHS England
  • Dr Lynn Calman, University of Southampton
  • Professor Stephen Duffy, Queen Mary University of London
  • Professor Michelle Turner, Instituto de Salud Global Barcelona
  • Dr Serena Nik-Zainal, MRC Cancer Unit
  • Dr Robert Rintoul, University of Cambridge
  • Dr Fiona McDonald, Royal Marsden NHS Foundation Trust
  • Dr Sanjay Popat, Royal Marsden NHS Foundation Trust
  • Dr Martin Forster, University College London


  • Professor Fiona Blackhall, Christie NHS Foundation Trust
  • Dr Mary O’Brien, Royal Marsden NHS Foundation Trust

Who should attend?
Professionals interested in research focused on the improvement of detection, treatment and outcomes of lung cancer in never smokers, including Scientists, Medical/Clinical Oncologists, Surgeons, Early career researchers, Nurses, Allied Health Professionals, PhD students, Research managers/Funders, Consumers and PPI


May 19 2021


9:00 am - 4:30 pm



Sponsored by:

Bristol Myers Squibb
Bristol Myers Squibb
The Ruth Strauss Foundation
The Ruth Strauss Foundation